SC 13D
NEW ENTERPRISE ASSOCIATES 17, L.P. / MONTE ROSA THERAPEUTICS, INC. -- SCHEDULE 1
- Company
- Monte Rosa Therapeutics, Inc.
- Filed
- July 12, 2021
- Accession Number
- 0001072613-21-000469
A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →